Title of Collaborative Activity:
Influenza Vaccine Manufacturing Improvement Group
Description of Collaborative Activity:
The Influenza Vaccine Manufacturing Improvement Group aims to optimize donor strains, improve sterility assays, and develop alternative potency assays.
Type of Collaborative Activity:
Other
Year the Collaborative Activity Originated:
Unknown
NIH Participating Institutes/Centers/Office of the Director:
NIAID
HHS Agency Collaborators on this Activity:
CDC, FDA, OS